Sumitomo Mitsui Trust Group
EXAS

Sumitomo Mitsui Trust Group’s Exact Sciences EXAS Stock Holding History

Sumitomo Mitsui Trust Group’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-87,207
Closed -$8.86M – 1065
2025
Q4 		$8.86M Sell
87,207
-1,199,388
-93% -$96.3M 0.01% 688
2025
Q3 		$70.4M Buy
1,286,595
+1,113,459
+643% +$55.6M 0.04% 373
2025
Q2 		$9.2M Sell
173,136
-394,370
-69% -$20M 0.01% 680
2025
Q1 		$24.6M Sell
567,506
-377,455
-40% -$19.1M 0.02% 609
2024
Q4 		$53.1M Sell
944,961
-104,974
-10% -$6.53M 0.04% 431
2024
Q3 		$71.5M Sell
1,049,935
-92,841
-8% -$5.24M 0.05% 371
2024
Q2 		$48.3M Sell
1,142,776
-830,816
-42% -$45.7M 0.04% 435
2024
Q1 		$136M Sell
1,973,592
-235,658
-11% -$14.9M 0.09% 223
2023
Q4 		$163M Sell
2,209,250
-198,252
-8% -$13M 0.12% 178
2023
Q3 		$164M Sell
2,407,502
-237,348
-9% -$20.1M 0.13% 162
2023
Q2 		$248M Sell
2,644,850
-1,133,545
-30% -$88.4M 0.19% 111
2023
Q1 		$256M Sell
3,778,395
-1,586,204
-30% -$102M 0.19% 117
2022
Q4 		$266M Sell
5,364,599
-1,152,546
-18% -$47.1M 0.21% 107
2022
Q3 		$212M Buy
6,517,145
+709,540
+12% +$29.3M 0.17% 127
2022
Q2 		$229M Buy
5,807,605
+176,261
+3% +$9.43M 0.18% 123
2022
Q1 		$394M Sell
5,631,344
-251,836
-4% -$18.4M 0.26% 80
2021
Q4 		$458M Buy
5,883,180
+1,203,450
+26% +$106M 0.28% 76
2021
Q3 		$447M Buy
4,679,730
+936,245
+25% +$98.9M 0.28% 82
2021
Q2 		$465M Buy
3,743,485
+1,067,298
+40% +$127M 0.28% 81
2021
Q1 		$353M Buy
2,676,187
+836,874
+45% +$115M 0.22% 101
2020
Q4 		$244M Buy
1,839,313
+1,156,192
+169% +$140M 0.16% 144
2020
Q3 		$69.6M Buy
683,121
+95,224
+16% +$8.22M 0.05% 401
2020
Q2 		$51.1M Sell
587,897
-468
-0.1% -$37.4K 0.04% 486
2020
Q1 		$34.1M Buy
588,365
+25,138
+4% +$2.04M 0.03% 538
2019
Q4 		$52.1M Buy
563,227
+79,728
+16% +$7.01M 0.04% 469
2019
Q3 		$43.7M Sell
483,499
-34,632
-7% -$3.95M 0.04% 484
2019
Q2 		$61.2M Buy
+518,131
New +$52.2M 0.05% 367

Other funds holding EXAS

VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.16B AUM 28.78% 1-Year Est. Return
PWMAG
Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.68B AUM 31.18% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return
BC
Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

Sumitomo Mitsui Trust Group's EXAS Position: Q1 2026 in Review

Sumitomo Mitsui Trust Group sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 87,207 shares — an estimated $8.86M sold.

Sumitomo Mitsui Trust Group first reported a position in EXAS in Q2 2019 and held it in 27 quarters. The position peaked at $465M in Q2 2021. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Sumitomo Mitsui Trust Group reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Sumitomo Mitsui Trust Group sold 87,207 Exact Sciences shares in Q1 2026, an estimated $8.86M.
  • Sumitomo Mitsui Trust Group first reported a position in Exact Sciences in Q2 2019 and held it in 27 quarters.
  • Sumitomo Mitsui Trust Group's Exact Sciences position peaked at $465M in Q2 2021.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Sumitomo Mitsui Trust Group's 13F filing for Q1 2026, filed 30 Apr 2026.